FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Interpace Diagnostics (NASDAQ: IDXG) reported Q2 EPS of ($0.14), versus ($0.07) reported last year. Revenue for the quarter came in at $6.3 million, versus $5.5 million reported last year.
For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.
... More
